Summary

  • Genetic testing company 23andMe is filing for Chapter 11 bankruptcy in a bid to sell the business after years of financial difficulties.
  • The firm has suffered a plummet in value from 50m following difficulties turning a profit.
  • It recently announced job cuts of 40% as well as settling a lawsuit for $30m for failing to protect customer data.
  • Former CEO Anne Wojcicki will step down and bid for the company independently, with CFO Joe Selsavage taking on the CEO role on an interim basis.
  • 23andMe has said operations will continue as normal during the sale process, and customers’ data and subscriptions won’t be affected.

By Jess Weatherbed

Original Article